CDNA vs UNH

CareDx Inc continues to face significant challenges that make a 10x growth within 3-5 years highly improbable. The Q4 2025 EPS miss and negative TTM EBITDA highlight ongoing profitability struggles, reinforcing the previous assessment of a challenged financial trajectory and unsustainable path. While the company maintains a strong balance sheet with a 2.86x current ratio and low debt-to-equity of ...

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...